Stage I–IV cancer patients with high SERPINB5 mRNA expression showed a long overall survival time than those with its low expression (p < 0.05), while it was the same for progression-free survival in the patients with stage II and III cancer (p < 0.05). This evidence concerns the gene SERPINB5 and cancer.